Bosnia and Herzegovina vs Equatorial Guinea: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Bosnia and Herzegovina
54.0%
in 2025
Equatorial Guinea
53.0%
in 2025
Bosnia and Herzegovina rank
169th
Equatorial Guinea rank
170th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Bosnia and Herzegovina
- Equatorial Guinea
How they compare
Bosnia and Herzegovina currently reports 54.0% against 53.0% in Equatorial Guinea, a difference of 1.0%.
Across all 26 years both countries report, Bosnia and Herzegovina has been ahead every year.
Bosnia and Herzegovina ranks 169th and Equatorial Guinea ranks 170th of 194 countries.
Bosnia and Herzegovina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.1% | 0.0% | 88.1% | Bosnia and Herzegovina |
| 2010s | 85.0% | 0.0% | 85.0% | Bosnia and Herzegovina |
| 2020s | 62.8% | 23.7% | 39.2% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Bosnia and Herzegovina or Equatorial Guinea?
- Bosnia and Herzegovina, at 54.0% against 53.0% in Equatorial Guinea as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Bosnia and Herzegovina and Equatorial Guinea?
- 1.0%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Equatorial Guinea?
- 26 years are reported by both, from 2000 to 2025.
- How do Bosnia and Herzegovina and Equatorial Guinea rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Bosnia and Herzegovina ranks 169th and Equatorial Guinea ranks 170th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.